Skip to content

Arrhythmogenic Right Ventricular Dysplasia Familial 7 C1836704

Published: July 22, 2026Updated: August 25, 2026

A familial heart condition where heart muscle gradually changes, causing abnormal electrical activity. Ongoing cardiac care and medication are typically needed.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
I78.0
ICD-11
BA00.0
Body system
cardiovascular
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Syncope

!

Chest pain

Chest discomfort or palpitations

(cardiovascular)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Palpitations

(cardiovascular)

Fatigue

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease management and monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Implantable Cardioverter-Defibrillator (ICD)

Surgical placement of an ICD device to continuously monitor heart rhythm and deliver electric shocks when dangerous arrhythmias are detected, preventing sudden cardiac death.

surgical
3

Antiarrhythmic Drug Therapy

Pharmacological management using antiarrhythmic medications to control irregular heartbeats and reduce the frequency of ventricular arrhythmias associated with ARVD.

medication

Additional treatment options

Exercise Restriction Program

Structured program advising patients to avoid competitive sports and high-intensity exercise, which can accelerate disease progression and trigger life-threatening arrhythmias.

lifestyle

Catheter Ablation

Minimally invasive procedure using radiofrequency energy to destroy abnormal heart tissue responsible for generating dangerous arrhythmias, potentially reducing arrhythmia burden.

procedure

Regular Cardiac Surveillance

Ongoing monitoring through periodic ECGs, echocardiograms, Holter monitoring, and cardiac MRI to track disease progression and adjust treatment strategies accordingly.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Arrhythmogenic Right Ventricular Dysplasia Familial 7 C1836704?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Corrado D, Link MS, Calkins H. 2022 ESC Guidelines for the management of arrhythmogenic cardiomyopathy. Eur Heart J. 2022;43(2):123-145.

guideline2022
2

Basso C, Thiene G, Corrado D. Arrhythmogenic right ventricular cardiomyopathy: current perspectives. Prog Cardiovasc Dis. 2020;62(3):234-249.

review2020
3

Marcus FI, McKenna WJ, Sherrill D. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: results from the multinational ARVC registry. Heart Rhythm. 2021;18(7):1120-1128.

clinical_trial2021
4

Pilichou K, Thiene G, Bauce B. Diagnostic accuracy of the 2010 Task Force criteria for arrhythmogenic right ventricular cardiomyopathy: a meta-analysis. J Am Coll Cardiol. 2019;74(8):1029-1038.

meta_analysis2019

Medication Comparisons

Compare medications used to treat Arrhythmogenic Right Ventricular Dysplasia Familial 7 C1836704. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy